The calamitous events of 2020 redefined many priorities but also opened up potential and opportunities. This is particularly true of genetics and genome research. This field not only offers enormous potential in terms of healthcare, it can also pave the way for breakthroughs in other areas of the economy. Given the fact that genome work is perceived very differently in the East and the West, will the key to success lie in international cooperation and possibly new global standards? Who should take the lead in this field?